CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to PFE

Ritlecitinib higher dose

Phase 3
PFIZER (PFE)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
PFEPhase 3

Ritlecitinib higher dose Phase 3 Est. Readout

Ritlecitinib higher dose
Dec 2026~STALE
CT.gov
00%
Competitive Landscape

1 competitor in Severe Alopecia Areata

View Full Landscape
Drug Information

Target Indication

Severe Alopecia Areata

Clinical Trial

NCT07029711

Last updated: 12/18/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.